Vabysmo is the only injectable eye medicine approved simultaneously in the US for wet AMD and DME, with flexible dosing regimens based on patient need
Outlook 2024 remains flat CER sales growth and CORE EBITDA margin of high 20s
Lonza plans to invest approximately CHF 500 million to upgrade the facility
The U.S. FDA recently approved Xolair as the first and only medicine for children and adults with one or more food allergies
About 75% of all primary liver cancers in adults are HCC and up to 30% of HCC patients are eligible for embolisation
If approved, Xolair would be the first medicine to reduce allergic reactions to multiple foods following an accidental exposure
BioNTech's diverse pipeline includes multiple drugs in Phase I, II, and III clinical trials
Franson will help biopharma clients design a phased approach to inform and execute clinical development plans
Dr. Dietmar Berger, has agreed to take the leadership of the team ad interim
The company has been ranked 8th on the list this year for three key attributes: ‘innovative leader in the industry’, ‘is socially responsible’ and ‘has loyal employees’
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)